Products Tirabrutinib + Tirabrutinib + Tirabrutinib
Tirabrutinib + Tirabrutinib + Tirabrutinib Phase 2 Active ⚡ Active Refractory Primary Central Nervous System Lymphoma
Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma
Dec 29, 2021 → Mar 31, 2027
About Tirabrutinib + Tirabrutinib + Tirabrutinib Tirabrutinib + Tirabrutinib + Tirabrutinib is a phase 2 stage product being developed by Ono Pharmaceutical for Refractory Primary Central Nervous System Lymphoma. The current trial status is active. This product is registered under clinical trial identifier NCT04947319. Target conditions include Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT04947319 Phase 2 Active Dec 29, 2021 Mar 31, 2027 Refractory Primary Central Nervous System Lymphoma
Competing Products 20 competing products in Refractory Primary Central Nervous System Lymphoma
See all competitors Product Company Stage Hype Score Abemaciclib, dexamethasone, ixazomib, pomalidomide + Enasidenib, dexamethasone, ixazomib, pomalidomide + Cobimetinib, dexamethasone, ixazomib, pomalidomide + Erdafitinib, dexamethasone, ixazomib, pomalidomide + Venetoclax, dexamethasone, ixazomib, pomalidomide + Daratumumab, dexamethasone, ixazomib, pomalidomide + Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide + Selinexor, dexamethasone, ixazomib, pomalidomide Eli Lilly Phase 1/2 agenT-797 MiNK Therapeutics Phase 1 eFT508 + Avelumab eFFECTOR Therapeutics Phase 2 CT-P44(Daratumumab) + Darzalex Faspro(Daratumumab) Celltrion Phase 3 Valemetostat Tosylate Daiichi Sankyo Phase 2 Enzalutamide Astellas Pharma Phase 2 ASP1650 Astellas Pharma Phase 2 YM598 Astellas Pharma Phase 2 erlotinib + etoposide Astellas Pharma Phase 2 Mitoxantrone Hydrochloride Liposome & Enlonstobart Sun Pharmaceutical Phase 1/2 Lenvatinib + Everolimus Eisai Phase 1/2 perampanel + perampanel + perampanel + Placebo Eisai Phase 3 Eribulin mesilate + Irinotecan hydrochloride Eisai Phase 1/2 perampanel Eisai Phase 2 rabeprazole sodium Eisai Pre-clinical Lenvatinib Eisai Phase 2 E2007 (perampanel) + E2007 (perampanel) + Placebo Eisai Phase 3 E2007 (perampanel) + E2007 (perampanel) + Placebo Eisai Phase 3 Tazemetostat Eisai Phase 2 Rufinamide Eisai Phase 3
Other Products from Ono Pharmaceutical